AZ’s Airsupra (albuterol and budesonide ... treatment used to reduce exacerbations in people living with chronic obstructive pulmonary disease (COPD). Sales of Breztri were $677 million ...

In the MANDALA trial, Airsupra was found to significant reduce the risk of severe exacerbations compared to albuterol in patients ... pulmonary disease (COPD) in the US, with the first patients ...

With that in mind, one study examined whether Echinacea purpurea (along with vitamin D, selenium, and zinc) could relieve COPD exacerbations triggered by ... beta-2 agonist bronchodilators (for ...

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Healio Pulmonology has compiled the top news on COPD posted in 2024. Image: Adobe Stock A story on the link between muscle relaxant use and exacerbations in patients with COPD also made the top 5.

researchers compared heliox versus oxygen for delivery of continuous nebulized albuterol in 30 children aged 2 to 18 years with moderate to severe asthma exacerbations. The study was partially ...

The effects of equipotent doses of racemic albuterol and levalbuterol on heart rate (HR) in intensive care patients with and without baseline tachycardia were studied. Patients were included if ...

The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...